MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated by Silvia López-Borrego https://t.co/ZeeNF7TMUt
1,384 followers
19 followers
RT @MarValesLab: Our first publication of 2023 on the regulation of #NKG2D-ligands during MAPK inhibitors therapy in #melanoma highlights h…
44 followers
Our first publication of 2023 on the regulation of #NKG2D-ligands during MAPK inhibitors therapy in #melanoma highlights how #liquid #biopsy in plasma from cancer patients could allow monitoring immune competence during treatment. (cc: @Silvia_LopBor). htt
56 followers
RT @Silvia_LopBor: Excited to announce our latest research work in the regulation of #NKG2D-Ligands after MAPK inhibitors in #melanoma, pub…